COYA
Coya Therapeutics, Inc.
Key Financials
Revenue
$7.9M
↑ 123.6%
Operating Income
$-22555225
↓ 30.8%
Total Assets
$50.0M
↑ 12.6%
Net Income
$-21226107
↓ 42.6%
EPS (Diluted)
$-1.27
↓ 29.6%
Total Liabilities
$6.9M
↑ 45.1%
Cash & Equivalents
$46.8M
↑ 22.1%
Operating Cash Flow
$-10739301.00
↓ 4.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | COYA |
| Company Name | Coya Therapeutics, Inc. |
| CIK | 1835022 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 650.739.3939 |